Armata Pharmaceuticals (ARMP) Other Accumulated Expenses (2016 - 2026)
Armata Pharmaceuticals (ARMP) reported Other Accumulated Expenses of $372000.0 for Q1 2026, up 10.39% on a YoY basis from $337000.0 in Q1 2025, and down 23.61% sequentially from $487000.0 in Q4 2025.
Armata Pharmaceuticals (ARMP) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 6 years of Other Accumulated Expenses data on file, last reported at $372000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 10.39% year-over-year to $372000.0; the trailing twelve-month figure through Mar 2026 stood at $372000.0 (up 10.39% YoY), and the FY2025 full-year result was $487000.0, down 7.94% from the prior year.
- Other Accumulated Expenses retreated to $372000.0 in Q1 2026, from $487000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $529000.0 in Q4 2024 to a low of $124000.0 in Q2 2024.
- A 4-year average of $384700.0 and a median of $429500.0 in 2025 frame the typical range for Other Accumulated Expenses.
- Peak annual rise in Other Accumulated Expenses reached 10.48% in 2025, while the deepest fall reached 7.94% in 2025.
- Tracing ARMP's Other Accumulated Expenses over 4 years: stood at $523000.0 in 2023, then increased by 1.15% to $529000.0 in 2024, then dropped by 7.94% to $487000.0 in 2025, then fell by 23.61% to $372000.0 in 2026.
- Business Quant data shows ARMP's Other Accumulated Expenses at $372000.0 in Q1 2026, $487000.0 in Q4 2025, and $503000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 372,000.00 |
| Dec 31, 2025 | 487,000.00 |
| Sep 30, 2025 | 503,000.00 |
| Jun 30, 2025 | 137,000.00 |
| Mar 31, 2025 | 337,000.00 |
| Dec 31, 2024 | 529,000.00 |
| Sep 30, 2024 | 513,000.00 |
| Jun 30, 2024 | 124,000.00 |
| Mar 31, 2024 | 322,000.00 |
| Dec 31, 2023 | 523,000.00 |
| Sep 30, 2017 | 20,000.00 |
| Jun 30, 2017 | 408,000.00 |
| Mar 31, 2017 | 161,000.00 |
| Dec 31, 2016 | 185,000.00 |
| Sep 30, 2016 | 15,000.00 |
| Jun 30, 2016 | 15,000.00 |
| Mar 31, 2016 | 54,000.00 |